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Introduction
Covalent  histone  modifications  regulate  chromatin  structure 
and function. Methylation of lysine residues within histones H3 
and H4 by histone lysine methyltransferase complexes is one 
such modification. Depending on the site of the modified lysine 
residue and the extent of methylation (mono-, di-, or trimethyl-
ated), these modifications can lead to either activation or repres-
sion  of  transcription  (Ng  et  al.,  2009).  Emerging  evidence 
indicates an intimate link between abnormal histone methyla-
tion and human disease. Although histone lysine methyltrans-
ferase  complexes  primarily  reside  in  the  nucleus  and  target 
histones,  their  presence  in  the  cytosol  has  been  suggested   
(Su et al., 2005), and several nonhistone substrates have been 
identified (Huang and Berger, 2008). Based on our knowledge, 
whether a histone lysine methyltransferase complex or its sub-
units reside or function in the intracellular vesicular transport 
pathway is currently unknown. In this regard, an organellar pro-
teomic  study  has  detected  arginine  dimethylation  in  several 
Golgi proteins and revealed two putative Golgi-associated 
methyltransferases (Wu et al., 2004).
In mammals, at least five different SET1 family methyl-
transferase complexes target histone H3 lysine 4 (H3K4; Ru-
thenburg  et  al.,  2007;  Shilatifard,  2008).  Although  these 
complexes contain distinct catalytic subunits, they share com-
mon  components,  including  Ash2L,  RbBP5,  WDR5,  and 
mammal  Dpy-30  (mDpy-30).  Ash2L,  RbBP5,  and  WDR5 
form a stable core complex that confers substrate specificity 
and controls catalytic activity (Dou et al., 2006; Steward et 
al., 2006). Dpy-30 was originally identified as an essential 
component of Caenorhabditis elegans dosage compensation 
machinery (Hsu et al., 1995). However, Dpy-30 mutant males 
also  exhibit  growth  and  development  defects,  indicating  a 
general  function  of  this  protein.  Subsequent  studies  have   
demonstrated that the yeast and mammalian orthologues of 
Dpy-30, Sdc1 (Miller et al., 2001; Roguev et al., 2001) and 
mDpy-30 (Hughes et al., 2004; Cho et al., 2007), respectively, 
  H
istone  lysine  methyltransferase  complexes  are   
essential  for  chromatin  organization  and  gene 
regulation. Whether any of this machinery func-
tions in membrane traffic is unknown. In this study, we 
report  that  mammal  Dpy-30  (mDpy-30),  a  subunit  of 
several  histone  H3  lysine  4  (H3K4)  methyltransferase 
(H3K4MT)  complexes,  resides  in  the  nucleus  and  at   
the trans-Golgi network (TGN). The TGN targeting of 
mDpy-30 is mediated by BIG1, a TGN-localized guanine 
nucleotide exchange factor for adenosine diphosphate 
ribosylation  factor  GTPases.  Altering  mDpy-30  levels 
changes the distribution of cation-independent mannose 
6-phosphate receptor (CIMPR) without affecting that of 
TGN46 or transferrin receptor. Our experiments also in-
dicate that mDpy-30 functions in the endosome to TGN 
transport of CIMPR and that its knockdown results in the 
enrichment of internalized CIMPR and recycling endo-
somes near cell protrusions. Much like mDpy-30 deple-
tion,  the  knockdown  of  Ash2L  or  RbBP5,  two  other 
H3K4MT  subunits,  leads  to  a  similar  redistribution  of 
CIMPR. Collectively, these results suggest that mDpy-30 
and probably H3K4MT play a role in the endosomal 
transport of specific cargo proteins.
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library as a potential binding partner of a potassium channel 
in  a  yeast  two-hybrid  screen. Although  we  have  not  been   
able  to  confirm  the  interaction  between  mDpy-30  and  the 
channel  protein,  we  found  that  mDpy-30  localized  to  the 
Golgi apparatus and proceeded to examine the role of mDpy-
30 in vesicular traffic.
are  common  subunits  of  several  H3K4  methyltransferase 
(H3K4MT) complexes and that deletion of Sdc1 from yeast 
leads  to  a  greatly  reduced  level  of  H3K4  trimethylation   
(Schneider et al., 2005). Despite being a conserved H3K4MT 
subunit, the molecular function of mDpy-30 remains unknown.   
We  originally  isolated  mDpy-30  from  a  rat  brain  cDNA   
Figure 1.  Imaging analyses of perinuclear mDpy-30 in HeLa cells. (A–C) Cells were fixed in 3% formaldehyde, permeabilized with 0.1% saponin,   
immunostained, and visualized using conventional (A and B) or confocal (C) microscopy. Arrows indicate sites of colocalization. (A) Colocalization analysis 
of mDpy-30 and recycling endosomes (EGFP-Rab11), late endosomes (EGFP-Rab7), and lysosomes (Lamp1). (B) Colocalization analysis of mDpy-30 and 
the cis-Golgi network/cis-Golgi (p115), medial-Golgi (GRASP55), or TGN (TGN46) marker. (C) Colocalization analysis of mDpy-30 and p115 or TGN46.   
A representative image from single z section is shown (the full z stack for both are available in the JCB DataViewer; http://jcb-dataviewer.rupress.org/jcb/
browse/1505/2600). Pearson’s correlations were calculated from each image in the z stack of confocal microscopy images of the perinuclear regions 
(defined by p115 or TGN46) using the colocalization analysis from Image-Pro Plus 3.6 software (Media Cybernetics; Student’s t test, P = 5.02393 × 10
12; 
n = 14). Error bars indicate the standard deviation of the values obtained from individual cells. Bars, 10 µm.345 HISTONE METHYLTRANSFERASE AND ENDOSOMAL TRAFFICKING • Xu et al.
Figure 2.  Subcellular distribution analyses of CIMPR, TGN46, and TfnR in HeLa cells depleted of or overexpressing mDpy-30. All siRNAs were used at 
a concentration of 20 nM, and transfected cells were analyzed 48 h after transfection. Unless noted otherwise, the values shown in all bar graphs and 
Western blots are the mean results obtained from at least three independent experiments. For imaging analyses, >500 cells were counted in each experi-
ment. (A) Subcellular distributions of CIMPR, TGN46, or TfnR in HeLa cells treated with control nontargeting or mDpy-30 siRNAs. Cells were processed 
as described in Fig. 1. Arrows indicate cell protrusions. (B) Enrichment of CIMPR near cell protrusions (indicated by arrows) was confirmed by phalloidin 
F-actin costaining, and the fraction of cells displaying enriched CIMPR near protrusions was scored. (C) Western blot analysis of the CIMPR protein level 
after the knockdown of mDpy-30. The numbers represent the mean value of six independent experiments. (D) The effect of mDpy-30 overexpression on 
the localization of CIMPR or -GalT1 (compare asterisks with arrows). Only those cells exhibiting a high level of exogenous mDpy-30 were counted. The 
experiment was repeated once, and the mean value is shown. (E) The protein level of CIMPR in cells overexpressing mDpy-30. (B and E) Error bars indicate 
the standard deviation of the values obtained from independent experiments. Bars, 10 µm.JCB • VOLUME 186 • NUMBER 3 • 2009   346
Figure 3.  The role of mDpy-30 in the endosome to TGN transport of CIMPR in HeLa cells. Transfection and staining were performed as described in Figs.   
2 and 1, respectively, except in G and J where 0.1% Triton X-100 was used to assure even permeabilization of the nuclear membrane among cells. The values 
shown in all bar graphs and Western blots are the mean results obtained from at least three independent experiments. In the case of imaging analyses, 
>500 cells were counted in each experiment. Except in J, arrows and the arrowhead indicate cell protrusions. (A) The impact of mDpy-30 knockdown on 347 HISTONE METHYLTRANSFERASE AND ENDOSOMAL TRAFFICKING • Xu et al.
expressing mDpy-30 on the subcellular distributions of three 
cargo proteins that cycle among the TGN, plasma membrane 
(PM), and endosomes, including TGN46 (which traffics from 
the TGN to the PM to early/recycling endosomes and back to 
the TGN [Ghosh et al., 1998; Mallard et al., 2002; Ganley et al., 
2008]), CIMPR (which moves from the TGN to early/recycling 
endosomes to late endosomes and back to the TGN or from the 
TGN to the PM to early/recycling endosomes to late endosomes 
to the TGN [Ghosh et al., 2003]), and TfnR (which cycles be-
tween the PM and early/recycling endosomes [Maxfield and 
McGraw, 2004]).
We first compared the subcellular distributions of TGN46, 
CIMPR, and TfnR in HeLa cells transfected with a nontargeting 
control or mDpy-30 siRNA (see Fig. S2 for siRNA character-
ization). Although both control and mDpy-30 knockdown cells 
expressed a similar level of CIMPR (Fig. 2 C), depletion of 
mDpy-30 resulted in a five- to sixfold increase in the fraction of 
cells displaying an enrichment of CIMPR near cell protrusions 
(Fig. 2, A and B). In contrast, neither TGN46 nor TfnR became 
concentrated in these compartments. The distribution of CIMPR 
was also more sensitive to mDpy-30 overexpression (i.e., a re-
duced perinuclear and an increased dispersed staining compared 
with control cells) than those of -GalT1 (Fig. 2 D) and TGN46 
(not depicted). Moreover, the overexpression of mDpy-30 
caused a 25% reduction of CIMPR protein level (Fig. 2 E), pos-
sibly by promoting its lysosomal degradation.
Function of mDpy-30 in CIMPR  
endosomal transport
We next investigated the effect of depleting mDpy-30 on CIMPR 
endosomal transport in a HeLa cell line stably expressing a CD8 
fusion of CIMPR. A previous study has shown that the traffick-
ing properties of this fusion are identical to those of endogenous 
CIMPR (Seaman, 2004). Western blot analysis indicated that 
mDpy-30 knockdown had no significant influence on the level 
of CD8-CIMPR (Fig. 3 A).
We labeled surface CD8-CIMPR using an anti-CD8 anti-
body and followed the endosomal transport at different time 
points after internalization (Fig. 3, B and C). At 5 min after in-
ternalization, CD8-CIMPR was primarily found in peripheral 
vesicles (presumably early endosomes) in virtually all control 
and mDpy-30–depleted cells, suggesting that mDpy-30 depletion 
had no substantial impact on the internalization of CD8-CIMPR. 
Results and discussion
TGN localization of mDpy-30
Immunofluorescence study in multiple cell types revealed that 
mDpy-30 displayed an unanticipated dual localization, both   
nuclear and cytoplasmic (see Fig. S1 for antibody characteriza-
tion),  the  latter  of  which  was  enriched  at  a  perinuclear  site   
(Fig. S1 E). The following observations suggest that the dual 
localization is an intrinsic property of mDpy-30. First, an   
HA-tagged mDpy-30 exhibited a similar distribution when stably 
expressed in CV-1 cells (Fig. S1 G). Second, live cell imaging 
indicated that a pool of mDpy-30–monomeric RFP (monomeric 
RFP fused to the C terminus of mDpy-30) resided in a peri-
nuclear region in addition to the nucleus (Fig. S1 H). To define the 
identity of perinuclear mDpy-30 staining, we conducted a com-
parison between perinuclear mDpy-30 and subcellular markers 
known to reside in compartments near the nucleus (Fig. 1 A). 
We found little or no colocalization between mDpy-30 and 
recycling endosomes (labeled by an EGFP fusion of Rab11; 
Ullrich et al., 1996), late endosomes (EGFP fusion of Rab7; 
Meresse  et  al.,  1995),  and  lysosomes  (Lamp1;  Chen  et  al., 
1985). When compared with Golgi markers (Fig. 1 B), mDpy-30 
displayed little colocalization with p115, a cis-Golgi network/
cis-Golgi marker (Nelson et al., 1998), and GRASP55, a medial-
Golgi marker (Shorter et al., 1999). However, mDpy-30 staining 
was in close proximity to and partially overlapped with that of 
TGN46, a TGN marker (Ponnambalam et al., 1996). Similar re-
sults were obtained using confocal microscopy (Fig. 1 C and 
JCB DataViewer; http://jcb-dataviewer.rupress.org/jcb/browse/ 
1505/2600); Pearson’s correlation analysis indicated that there 
was a significantly higher correlation between the TGN46 and 
mDpy-30 staining than that of p115 and mDpy-30. Collectively, 
our data suggest that a pool of mDpy-30 is present at the TGN.
Altered subcellular distribution of  
cation-independent mannose 6-phosphate 
receptor (CIMPR) but not TGN46 or 
transferrin receptor (TfnR) in cells 
depleted of or overexpressing mDpy-30
As an H3K4MT subunit, the TGN localization of mDpy-30 was 
unexpected and implied a potential role of this protein in mem-
brane traffic. To test whether mDpy-30 was involved in TGN 
trafficking, we investigated the impact of depleting or over-
the protein level of CD8-CIMPR fusion expressed in a HeLa stable line. (B and C) The effect of mDpy-30 depletion on the endosomal transport of CD8-CIMPR 
monitored at different time points after internalization as described in Materials and methods. Cells were analyzed by eye using the following criteria. In B, 
cells were scored as perinuclear or mixed perinuclear/peripheral if internalized CD8-CIMPR could be detected as a distinct perinuclear structure in close 
proximity to TGN46. However, cells lacking such structure were scored as peripheral. In C, cells were scored based on whether internalized CD8-CIMPR 
became enriched near cell protrusions as described in Fig. 2 B. (D) The influence of knocking down mDpy-30 on the endosomal transport of endogenous 
CIMPR in HeLa cells was assessed after adding anti-CIMPR antibody to the culture medium for 1 h at 37°C. (E) The comparison of the endosomal trans-
port of CD8-CIMPR and TfnR in mDpy-30–depleted HeLa stable cells. Surface TfnR and CD8-CIMPR were labeled with biotinylated transferrin and the 
anti-CD8 antibody, respectively, and their endosomal transport was examined at 5, 10, and 20 min after internalization. (F) EEA1 staining was absent at 
the CD8-CIMPR–enriched cell protrusions. Nu, nucleus. (G and H) The influence of depleting Ash2L or RbBP5 (two H3K4MT components) and SUV39H1   
(a component of H3K9MT) on the targeting of internalized CD8-CIMPR to cell protrusions. The effectiveness of Ash2L and RbBP5 siRNAs was examined 
using immunofluorescence and Western blot (see I) analyses. Cells were scored according to the criteria described in Fig. 2 B, and the result is shown 
in the bar graph. (I) The impact of knocking down Ash2L or RbBP5 on the protein level of mDpy-30. The level of GAPDH (glyceraldehyde-3-phosphate   
dehydrogenase) was used as a loading control. (J) The effects of Ash2L or RbBP5 overexpression on the localization of CIMPR or -GalT1 (compare aster-
isks with arrows). (B, C, H, and J) Error bars indicate the standard deviation of the values obtained from independent experiments. Bars, 10 µm.
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At 15 min after internalization, a pool of CD8-CIMPR had 
reached a perinuclear site in 75% of the control cells; this 
perinuclear compartment became the most prominently stained 
structure in the majority of cells. However, the fraction of cells 
displaying  perinuclear  localization  of  CD8-CIMPR  was  re-
duced in mDpy-30 knockdown cells (52% for siRNA1 and 27% 
for  siRNA2).  Even  in  those  cells  exhibiting  a  perinuclear   
CD8-CIMPR staining, a large fraction of fusion proteins remained 
in peripheral endosomes throughout the cytosol (Fig. 3 C). The 
difference in the perinuclear targeting of CD8-CIMPR persisted 
after 45 min of internalization. Accompanying this decreased effi-
ciency in targeting internalized CD8-CIMPR to the perinuclear 
Figure 4.  Characterization of the CIMPR-enriched compartment at cell protrusions. Transfection and staining were conducted as described in Figs. 2 
and 1, respectively. Arrows indicate cell protrusions. (A) The localization of STX10 and VAMP3 after mDpy-30 knockdown. (B) Colocalization analysis of 
internalized CD8-CIMPR and STX10 or VAMP3 near cell protrusions. Internalization was performed as described in Fig. 3. Nu, nucleus. (C and D) The 
influence of mDpy-30 knockdown on the localization of various endosomal Rab proteins in HeLa–CD8-CIMPR stable cells. EGFP fusions of Rab proteins 
were transfected into cells pretreated with a nontargeting control or mDpy-30 siRNA2, and transfected cells were scored according to the criteria described 
in Fig. 2 B. The numbers in the bar graph represent the mean result from five independent experiments (n > 500 in each experiment). Error bars indicate 
the standard deviation of the values obtained from independent experiments. Similar results were obtained with mDpy-30 siRNA1, albeit with less effect 
(not depicted). Bars, 10 µm.349 HISTONE METHYLTRANSFERASE AND ENDOSOMAL TRAFFICKING • Xu et al.
Moreover, similar to mDpy-30 overexpression, overexpres-
sion of either Ash2L or RbBP5 increased the fraction of cells 
displaying a dispersed CIMPR distribution without changing 
that of -GalT1 (Fig. 3 J). These results indicate a link between 
H3K4MT and the endosomal transport of CIMPR.
Characterization of the CIMPR-positive 
peripheral compartment in mDpy-30 
knockdown cells
Considering that the STX10–STX16–Vti1A–VAMP3 SNARE 
complex mediates the endosome to TGN transport of CIMPR 
(Ganley et al., 2008), we asked whether CIMPR colocalized 
with STX10 and VAMP3 at cell protrusions. Compared with 
control cells, after mDpy-30 knockdown, a pool of STX10 and 
VAMP3 also became enriched near cell protrusions (Fig. 4 A), 
where they exhibited a partial colocalization with internalized 
CD8-CIMPR (Fig. 4 B). However, VAMP4 and VAMP8, two 
other  SNARE  proteins  along  the  TGN–PM–endosome  loop 
(Cocucci et al., 2008; Kanwar et al., 2008), displayed little or 
only  modest  enrichment  and  little  to  no  colocalization  with 
CD8-CIMPR within this region (unpublished data).
To better define the CIMPR-positive compartment near 
cell  protrusions,  we  investigated  the  distributions  of  Rab   
GTPase proteins in control and mDpy-30 knockdown cells. Each 
Rab protein has a compartment-specific localization and plays 
an essential role in defining the compartmental function in traf-
ficking (Cai et al., 2007; Markgraf et al., 2007; Nielsen et al., 
2008). For example, Rab4, -5, and -11 all reside in early endo-
somal compartments with distinct functions. Rab5 modulates 
endocytosis, and Rab4 and -11 control the endosomal recycling 
from early and recycling endosomes, respectively. However, 
Rab7 and -9 primarily function during the late endosomal traf-
ficking, and Rab6 is thought to regulate endosome to TGN 
transport. As indicated in Fig. 4 (C and D), knockdown of 
mDpy-30 induced enrichment of Rab11 and, to an even higher 
extent, Rab4 at cell protrusions without significantly affecting 
the distributions of Rab5, -6, -7, and -9. This observation im-
plies that the depletion of mDpy-30 causes a subpopulation of 
recycling endosomes to be enriched at cell protrusions.
BIG1-mediated recruitment of  
mDpy-30 to the TGN
To  gain  mechanistic  insight  into  how  mDpy-30  modulates   
endosomal trafficking, we set out to identify proteins interacting 
with mDpy-30. We generated CV-1 cells stably expressing a 
GFP fusion of mDpy-30 and used an anti-GFP antibody co-
valently linked to magnetic microbeads to immunoprecipitate 
mDpy-30–EGFP and its associated proteins. Tandem mass spec-
trometry analysis of the immunoprecipitate revealed several 
known mDpy-30–interacting partners, including Ash2L and 
WDR5 (two H3K4MT components), as well as a novel inter-
acting partner, BIG1 (a TGN-localized ADP ribosylation fac-
tor guanine nucleotide exchange factor; Fig. 5 A; Morinaga   
et al., 1997). We confirmed the mDpy-30–BIG1 interaction using 
coimmunoprecipitation between mDpy-30 and a HA-tagged 
BIG1 (Fig. 5 B) as well as between endogenous mDpy-30 and 
BIG1 (Fig. 5 C). Furthermore, mDpy-30 and BIG1 colocalized 
region, there was a time-dependent enrichment (a fourfold   
increase for siRNA1 or -2) of fusion proteins at a compart-
ment near the protrusions of mDpy-30–depleted cells (Fig. 3, 
B and C). To confirm that mDpy-30 knockdown exerted a   
similar effect on endogenous CIMPR, we added the anti-
CIMPR antibody to the culture medium of HeLa cells for 1 h at 
37°C.  The  antibody  labeling  and  internalization  steps  were 
combined and lengthened to improve the signal strength of in-
ternalized endogenous CIMPR (Fig. 3 D). As with CD8-CIMPR, 
a fraction of CIMPR was found near protrusions in mDpy-30–
depleted cells. Because the endosomal transport of a CD8-furin 
fusion was altered by mDpy-30 siRNA in a similar way (un-
published data), the effect of mDpy-30 on trafficking was not   
specific to CIMPR.
The observation that the level of CD8-CIMPR at the pro-
trusions of mDpy-30 knockdown cells increased within 45 min 
of internalization implied that mDpy-30 functions at a late   
endosomal transport step. To test this, we simultaneously com-
pared  the  endosomal  transport  of  TfnR  (via  biotinylated 
transferrin) and CD8-CIMPR. As shown in Fig. 3 E, at 5 min 
after internalization, CD8-CIMPR and TfnR colocalized at an 
early endosomal compartment in both control (not depicted) 
and mDpy-30–depleted cells. At 10 or 20 min after internaliza-
tion, TfnR entered tubular recycling endosomes, but there was 
little colocalization with CD8-CIMPR, indicating that these 
proteins had been sorted into different pathways after their tran-
sit through the early endosomes. This was in accordance with a 
lack of EEA1 (a marker of early endosomes) staining in the 
protrusion regions where internalized CD8-CIMPR became 
enriched (Fig. 3 F).
Collectively, our data suggest that mDpy-30 regulates the 
late endosomal trafficking of a subset of cargo proteins such as 
CIMPR and furin. Given the TGN localization of mDpy-30 as 
well as the inefficient return of internalized CD8-CIMPR to a 
perinuclear site, mDpy-30 is probably involved in the endosome 
to TGN transport of CIMPR. In the absence of mDpy-30, a pool 
of CIMPR is redirected to endosomes near cell protrusions. 
However, we cannot exclude a role of mDpy-30 in the transport 
between endosomes or from the TGN to endosomes. Moreover, 
because mDpy-30 knockdown also reduced the H3K4 trimethyl-
ation (Fig. S2 E), our data do not allow us to distinguish whether 
mDpy-30 modulates CIMPR trafficking via transcription or 
posttranscriptional effects or both.
A role of the H3K4MT complex or 
complexes in the endosomal transport  
of CIMPR
To explore H3K4MT involvement in trafficking, we examined 
the endosomal transport of CD8-CIMPR after knocking down 
either Ash2L or RbBP5, two other common H3K4MT subunits 
(Fig. 3, G and H). Indeed, cells transfected with either of the 
two siRNAs against Ash2L or RbBP5 accumulated internalized 
CD8-CIMPR near cell protrusions. The effect of Ash2L or 
RbBP5 siRNAs on CIMPR was not caused by their impact on 
the level of mDpy-30 protein (Fig. 3 I). In contrast, treatment   
of cells with an siRNA against SUV39H1, a component of   
the H3K9MT complex (Rea et al., 2000), exerted little effect. JCB • VOLUME 186 • NUMBER 3 • 2009   350
expression of BIG1 led to an enhanced staining of perinuclear 
mDpy-30 (Fig. 5 F). Thus, our data show that BIG1 plays a   
major role in recruiting mDpy-30 to the TGN.
at the perinuclear TGN region (Fig. 5 D). Interestingly, BIG1 
depletion greatly reduced the TGN staining of mDpy-30 with-
out affecting -GalT1 localization (Fig. 5 E). However, over-
Figure 5.  BIG1-mediated TGN targeting of mDpy-30. (A) Identification of mDpy-30–interacting proteins by immunopurification and tandem mass spectros-
copy from CV-1 cells stably expressing an EGFP fusion of mDpy-30 (see Materials and methods). Question marks indicate bands that remain unidentified. 
(B and C) Coimmunoprecipitation of endogenous mDpy-30 and transfected HA-tagged BIG1 (B) or endogenous BIG1 (C). An equal amount of cell lysate 
was used for coimmunoprecipitation in all samples. IP, immunoprecipitation; WB, Western blot. (D) Colocalization of BIG1 and mDpy-30 (indicated by 
arrows). (E) Influence of depleting BIG1 on the perinuclear targeting of mDpy-30. The punctate staining of BIG1 in the cytoplasm is background. (F) Impact 
of overexpressing BIG1 on the perinuclear targeting of mDpy-30 (compare asterisks with arrows). Bars, 10 µm.351 HISTONE METHYLTRANSFERASE AND ENDOSOMAL TRAFFICKING • Xu et al.
CD8 (Millipore), p115 (BD), GRASP55 (a gift from F. Barr, University of 
Liverpool, Liverpool, England, UK), -GalT1 (a gift from U. Mandel, Univer-
sity  of  Copenhagen,  Copenhagen,  Denmark),  TGN46  (a  gift  from   
S. Ponnambalam, University of Leeds, Leeds, England, UK; Abcam), CIMPR 
(BioLegend),  Lamp1  (Developmental  Studies  Hybridoma  Bank),  EEA1 
(Sigma-Aldrich), VAMP3 (Synaptic Systems GmbH), and syntaxin 10 (a gift 
from B.L. Tang and W. Hong, National University of Singapore, Singa-
pore,  Republic  of  Singapore).  Biotin-transferrin  was  obtained  from   
Invitrogen. The siRNAs used in this study are mDpy-30 siRNA1–3 (target 
sequences: siRNA1, 5-CACCAAATCCCATTGAATT-3; siRNA2, 5-AAAC-
GCAGGTTGCAGAAAA-3; siRNA3, 5-AGACAACGTTGAGAGAATA-3; 
Thermo Fisher Scientific), Ash2L siRNA1 and -2 (target sequences: siRNA1, 
5-CCGAGTAACTAACTTATTTAA-3; siRNA2, 5-CCCGTTTAACAAAGAT-
GGCTA-3; QIAGEN), RbBP5 siRNA1 and -2 (target sequences: siRNA1, 
5-CAGGTGTCTCTCAACAAGCTA-3; siRNA2, 5-ACGGCAGATCGAA-
TAATCAGA-3; QIAGEN), and SUV39 siRNA1 (target sequence: 5-GCG-
GGTCCGTATTGAATGCAA-3; QIAGEN). The nontargeting control siRNA 
was obtained from QIAGEN (AllStars Negative Control siRNA).
Expression of recombinant mDpy-30 protein
The cDNA of rat mDpy-30 was cloned into the BamHI–HindIII sites of 
pUH21.2 vector and transformed into Escherichia coli. Transformants were 
grown in lysogeny broth medium containing 5 g/liter NaCl until the cell 
density reached an OD600 of 0.6. Expression of mDpy-30 protein was then 
induced using 1 mM isopropyl--d-thiogalactopyranoside for 3 h.
Cell culture and transfection
COS-7, CV-1, J774, and HeLa cells were cultured in advanced DME (Invit-
rogen) supplemented with 4% fetal bovine serum, 2 mM glutamine, and   
1× penicillin-streptomycin (Cellgro). The same medium was used to grow 
flippase  recombination  enzyme  (Flp)–In–CV-1–mDpy-30–HA  (Invitrogen) 
stable cells and HeLa–CD8-CIMPR or HeLa–CD8-furin stable cell lines ex-
cept that 200 µg/ml hygromycin and 100 µg/ml G418 were added, re-
spectively, for maintenance purposes. To generate Flp-In–CV-1–mDpy-30–HA 
or Flp-In–CV-1–mDpy-30–EGFP, the mDpy-30–HA or mDpy-30–EGFP fu-
sion was inserted into pcDNA5/Flp recombination target, transfected into 
Flp-In–CV-1 (Invitrogen) and selected by hygromycin according to the manu-
facturer’s instructions (Invitrogen). When needed, cells were transfected 
with DNA using FuGENE6 or FuGENE HD (Roche) or siRNA using Lipo-
fectamine 2000 (Invitrogen), and the effects of transfection were investi-
gated 24 h (for DNA) or 48 h (for siRNA) after the transfection, respectively. 
All siRNAs were used at a concentration of 20 nM.
SDS-PAGE and Western blot analysis
Untreated or transfected cells were solubilized in ice-cold radioimmuno-
precipitation assay lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
1 mM EDTA, 1% NP-40, 0.5% Na deoxycholate, and 0.1% SDS comple-
mented with complete protease inhibitors [Roche] and 1 mM PMSF) and 
cleared by centrifugation at 4°C. Core histones were prepared using a 
Histone Preparation Mini kit (Active Motif). Cell lysates were quantitated 
using the Non-Interfering Protein Assay kit according to the manufacturer’s 
instruction (G-Biosciences) and then denatured in SDS-PAGE loading buffer 
(with the reducing agent omitted for CIMPR). An equal amount of total pro-
tein per sample was then loaded into each well, separated by SDS-PAGE 
electrophoresis  (6–15%  gels;  Bio-Rad  Laboratories),  and  transferred  to   
Immobilon 0.45-µM polyvinylidene difluoride membranes (Millipore) using 
a Semi Dry Electroblotting System (Owl). Membranes were incubated with 
appropriate primary antibody for 1 h in a 1:1 mixture of blocking buffer 
(Odyssey) and PBS supplemented with 0.1% Tween 20, washed with PBS 
supplemented with 0.1% Tween 20 (three times for 5 min each), incubated 
with appropriate secondary antibody (Odyssey) for 30 min in a 1:1 mix-
ture of Odyssey blocking buffer and PBS supplemented with 0.1% Tween 
20 and 0.01% SDS, washed first with PBS supplemented with 0.1% Tween 
20 (three times for 5 min each) followed with PBS for 5 min, and dried in 
the dark. Fluorescence quantification was performed on an Infrared Imag-
ing System (model 9120; Odyssey).
Immunofluorescence analysis
Cells or transfected cells were fixed in PBS containing 3% formaldehyde for 
15 min, permeabilized with PBS containing 0.1% saponin or Triton X-100 
for 15 min, blocked in Blocker Casein in PBS (Thermo Fisher Scientific) 
containing 5% goat serum for 30 min, incubated with primary antibody in 
the blocking buffer for 2 h, washed in PBS three times for 5 min each, incu-
bated with fluorophore-conjugated secondary antibody in the blocking buf-
fer for 1 h, washed in PBS three times for 5 min each, incubated in PBS 
containing 1 µg/ml DAPI for 5 min, and washed in PBS three times for   
In this study, we have presented evidence supporting an un-
expected link between H3K4MT and endosomal transport. Our 
findings raise several intriguing questions for future studies.   
To begin, the mechanism by which mDpy-30 and H3K4MT 
regulate the endosomal transport remains unknown. One possi-
bility is that mDpy-30, Ash2L, and RbBP5 are components of a 
yet to be identified methyltransferase complex at the TGN 
where they affect endosomal transport by controlling the methyl-
ation of a trafficking regulator. However, we have not been 
able to detect the Golgi localization of either Ash2L or RbBP5 
using multiple antibodies or their GFP fusions (unpublished 
data). Another possibility is that the TGN pool of mDpy-30 co-
ordinates with nuclear H3K4MT to modulate endosomal trans-
port. The identification of BIG1 as an mDpy-30–interacting 
protein may provide clues to the aforementioned question. Both 
BIG1 and BIG2, a structurally similar ADP ribosylation factor 
guanine nucleotide exchange factor also found at the TGN 
(Yamaji et al., 2000), are involved in endosome to TGN trans-
port (Ishizaki et al., 2008) and/or TGN maintenance (Manolea 
et al., 2008). Intriguingly, the nuclear accumulation of BIG1 in 
HepG2 cells has been observed under serum starvation condi-
tions (Padilla et al., 2004) and PKA activation (Citterio et al., 
2006). It will be interesting to investigate whether mDpy-30 
regulates BIG1 function and whether BIG1 influences H3K4MT 
activity. Another question regards the physiological significance 
of our observations. Increasing evidence has implicated CIMPR 
in cell migration (Chapman, 1997; Roshy et al., 2003; Joyce 
and Hanahan, 2004; Wood and Hulett, 2008). Moreover, Rab4 
and -11 (Caswell and Norman, 2006) and VAMP3 (Proux- 
Gillardeaux et al., 2005; Tayeb et al., 2005) all impact integrin 
trafficking and cell adhesion/migration. The fact that knockdown 
of mDpy-30 or other H3K4MT components results in an enrich-
ment of Rab4- or Rab11-positive endosomes at cell protrusions 
suggests that H3K4MT may regulate cell adhesion/migration 
via modulating endosomal recycling. It is important to see 
whether the Rab4- and Rab11-positive compartments accumu-
lated at the protrusions of mDpy-30–depleted cells indeed have 
a recycling function and to determine what types of cargo pro-
teins besides CIMPR and furin transit via these compartments. 
Given a key role of local endocytosis and recycling of integrins 
at the cell leading edge in migration (Caswell and Norman, 
2008), it will be tempting to examine how the local trafficking 
of integrins is changed in cells depleted of mDpy-30 and other 
H3K4MT components and how this change regulates cell 
adhesion/migration.
Materials and methods
DNA constructs and reagents
mDpy-30  was  cloned  from  a  yeast  two-hybrid  rat  brain  cDNA  library 
(Clontech Laboratories, Inc.). The full-length cDNA was PCR amplified and 
inserted  into  a  bacterial  (pUH21.2;  a  gift  from  H.  Bujard,  European   
Molecular Biology Organization, Heidelberg, Germany) or mammalian 
(pcDNA3.1; Invitrogen) expression vector. A HA epitope (YPYDVPDYA) or 
EGFP (Clontech Laboratories, Inc.) was added to the C terminus of mDpy-30 
when needed. Rab cDNA clones were gifts from C. Bucci (Università   
degli Studi di Lecce, Lecce, Italy). The pCMV-HA-BIG1 expression construct 
was a gift from M. Vaughan (National Institutes of Health, Bethesda, MD). 
The antibodies used in this study are monoclonal anti-HA (HA.11; Co-
vance), polyclonal anti-HA (ICL), BIG1 (Santa Cruz Biotechnology, Inc.), JCB • VOLUME 186 • NUMBER 3 • 2009   352
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5 min each. Immunostained cells were allowed to air dry, mounted, and 
examined with a microscope (IX-81; Olympus).
Conventional microscopy
An IX-81 microscope was used in the epifluorescence experiments. A Plan-
Apochromat 60× oil total internal reflection fluorescence microscope ob-
jective (Olympus) with a 1.45 aperture was used throughout. All microscopy 
was performed at room temperature. Slides were mounted in SlowFade 
Gold antifade reagent (Invitrogen). Our secondary antibodies were conju-
gated to either Alexa Fluor 488 or Rhodamine red-X (appearing as green 
and red in the images, respectively). A monochrome digital camera (Evolu-
tion QEi; Media Cybernetics) mounted to the Olympus microscope and the 
in vivo acquisition software version 3.2.0 (Media Cybernetics) were used 
to capture images and analyze the microscope images. Finally, to crop the 
images for publication, we used Photoshop (Adobe) and Illustrator (Adobe) 
software packages.
Confocal microscopy
Images of the cells were captured with a laser-scanning confocal micro-
scope (Fluoview 500; Olympus) with a 40× Plan-Apochromat NA 1.3 lens. 
Two laser lines were used at 488 and 543 nm to excite the fluorochromes. 
Sequential color image capture was used to collect images. To record the 
distribution of label from apical to basal portions of the cell, a z series of 
20 images was captured of the cells at 0.5-µm steps.
Immunoprecipitation
Cells or transfected cells were solubilized in ice-cold NP-40 lysis buffer   
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, and 1% NP-40 
complemented with complete protease inhibitor and 1 mM PMSF) and 
cleared by centrifugation at 4°C. Immunoprecipitates were collected by a 
brief centrifugation after incubating the supernatant with a primary anti-
body for 1 h followed by protein G–Sepharose (Invitrogen) for 2 h at 4°C. 
The Sepharose beads were washed four times in ice-cold lysis buffer and 
once with PBS, and the bound proteins were eluted with SDS–PAGE sam-
ple buffer at 55°C for 1 h or at 90°C for 10 min.
Identification of mDpy-30–interacting proteins by immunopurification  
and mass spectroscopy
To purify mDpy-30–associated proteins, a mouse monoclonal anti-GFP anti-
body covalently linked to magnetic microbeads (µMACS GFP Tagged Protein 
Isolation kit; Miltenyi Biotec) was used to immunoprecipitate the mDpy-30–
EGFP  and  its  associated  proteins  from  the  Flp-In–CV-1–mDpy-30–EGFP   
stable cells under a stringent wash condition (650 mM NaCl, 1% Igepal 
CA-630,  0.5%  Na  deoxycholate,  0.1%  SDS,  and  50  mM  Tris-HCl,   
pH 8.0). Flp-In–CV-1 cells stably expressing EGFP alone were included   
as a negative control. The immunoprecipitates were then separated 
on SDS-PAGE and stained with SYPRO RUBY. The putative mDpy-30–associated 
protein bands were excised, eluted, and subjected to digestion, and the 
resulting peptides were resolved on a reverse-phase liquid chromatog-
raphy system and detected by coupled tandem mass spectrometry (micro-
capillary  high  performance  liquid  chromatography  system  [NanoFlow 
1100; Agilent Technologies] connected to a mass spectrometer [ESI-QToF 
2; Micromass]).
Internalization assay
HeLa–CD8-CIMPR (or HeLa–CD8-furin) cells were blocked in PBS contain-
ing 2% normal goat serum for 30 min and incubated with 1 µg/ml anti-CD8 
antibody in PBS containing 2% goat serum for 1 h at 0°C to label the   
surface fusion proteins. After removing the unbound antibodies by PBS 
wash at 0°C three times for 5 min each, cells were transferred into pre-
warmed culture medium and returned to 37°C to allow internalization to 
proceed  for  the  indicated  periods  of  time  before  immunofluorescence 
study. To monitor the endosomal transport of endogenous CIMPR in HeLa 
cells, anti-CIMPR antibody was added to the culture medium at 5 µg/ml for 
1 h at 37°C before fixation to enhance the internalization signal by allow-
ing continuous labeling and internalization.
Online supplemental material
Fig. S1 shows the characterization of the rabbit polyclonal anti–mDpy-30 
antibody using Western blot analyses, immunoprecipitation, and immuno-
fluorescence microscopy. Fig. S2 shows the characterization of three   
different mDpy-30 siRNAs and the knockdown efficiency of different pools 
of mDpy-30 as well as the effect of mDpy-30 knockdown on H3K4 tri-
methylation. Online supplemental material is available at http://www.jcb 
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